Pi et al. [33] analyzed that cBioPortal (cBio Cancer Genomics Portal) datasets including 630 primary gastric adenocarcinoma patients and revealed that YTHDF1, as a general oncogenic role, was mutated in 7% of patients with gastric cancer and YTHDF1 with high expression was correlated with more aggressive tumor progression and poor overall survival. The gene discussed is YTHDF1; the disease is gastric adenocarcinoma.